Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Pharm ; 182(1): 111-9, 1999 May 10.
Artigo em Inglês | MEDLINE | ID: mdl-10332080

RESUMO

Drug interactions with diosmectite, a gastric-protective drug, were studied in vitro using an artificial stomach-duodenum model. The behavior of neutral and ionisable drugs with pKa values ranging between 2 and 8 was monitored to determine the physicochemical characteristics of the interactions. The main neutral (digoxin) and acid (valproic acid) drug substances were moderately fixed by clay (<27%), in a pH-independent manner. Basic compounds with a pKa<7 (dapsone, metronidazole, cimetidine) were strongly fixed in acid medium (?62%), and fully released under neutral conditions. Amphoteric (fluoroquinolones) and basic compounds with a pKa>/=7 (ranitidine, pyrimethamine) were adsorbed by more than 81% by diosmectite in gastric and duodenal compartments. In the part of the model representing the distal duodenum, the potential site for drug absorption, only the active substances which remained positively charged (amphoteric and basic compounds) showed a large reduction (>/=80%) in their available free fraction. Ionisation of drug substances administered per os concomitantly with diosmectite plays a crucial role in these interactions.


Assuntos
Duodeno/fisiologia , Fármacos Gastrointestinais/farmacologia , Modelos Biológicos , Farmacocinética , Silicatos , Estômago/fisiologia , Adsorção , Animais , Anti-Infecciosos/farmacocinética , Cimetidina/farmacocinética , Dapsona/farmacocinética , Digoxina/farmacocinética , Interações Medicamentosas , Duodeno/metabolismo , Fluoroquinolonas , Mucosa Gástrica/metabolismo , Concentração de Íons de Hidrogênio , Absorção Intestinal/efeitos dos fármacos , Metronidazol/farmacocinética , Suínos , Ácido Valproico/farmacocinética
2.
Antimicrob Agents Chemother ; 40(5): 1219-24, 1996 May.
Artigo em Inglês | MEDLINE | ID: mdl-8723470

RESUMO

The activity of penicillin, alone and in combination with sulbactam, against a heterogeneously methicillin-resistant, penicillinase-producing clinical isolate of Staphylococcus aureus and its penicillinase-negative derivative was investigated in vitro and in a rabbit experimental endocarditis model. Penicillin was significantly more effective than vancomycin against the penicillinase-negative derivative in vivo (P < 0.001), and it sterilized 25% of the vegetations. The combination of penicillin and sulbactam exhibited an in vivo synergistic effect on the penicillinase-producing strain (P < 0.01) but did not produce any advantage over treatment with vancomycin, even when a high dose of sulbactam was used (100 mg/kg of body weight every 6 h). This combination was significantly less effective against the penicillinase-producing strain than was penicillin alone against the penicillinase-negative derivative (P < 0.03). In addition, the most resistant subpopulation of the surviving bacteria, which grew on agar containing 16 micrograms of methicillin per ml, was detected in 5 of 6 animals treated with penicillin and a high dose of sulbactam against the penicillinase-producing strain compared with only 1 of 12 animals treated with penicillin alone against the penicillinase-negative derivative (P < 0.01). We conclude that penicillin is highly effective against penicillinase-negative methicillin-resistant S. aureus and that penicillinase production, rather than methicillin resistance, appears to be the limiting factor for the activity of the penicillin-sulbactam combination against penicillinase-producing, methicillin-resistant S. aureus.


Assuntos
Quimioterapia Combinada/uso terapêutico , Endocardite/tratamento farmacológico , Resistência a Meticilina , Penicilinase/biossíntese , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus aureus/enzimologia , Animais , Sinergismo Farmacológico , Quimioterapia Combinada/farmacologia , Feminino , Penicilinas/farmacologia , Penicilinas/uso terapêutico , Coelhos , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/genética , Sulbactam/farmacologia , Sulbactam/uso terapêutico
3.
Therapie ; 51(2): 147-54, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8763049

RESUMO

We have developed an artificial stomach-duodenum model made up of three compartments representing the stomach, (including a fragment of hog gastric mucosa), the proximal duodenum, and the distal duodenum. Gastroduodenal flow rates are controlled by a microcomputer capable of (1) adjusting gastric emptying and alkaline secretion in the proximal duodenum according to intragastric pH; (2) adjusting pancreatic alkaline secretion according to proximal duodenum pH; and (3) simulating acid response to food ingestion. Antacid drugs were added 90 min after simulated food ingestion in near-physiological or duodenal ulcer conditions. Aluminum phosphate-containing antacids resulted in a persistent antacid effect, due to their adsorption to the gastric mucosa; this prolonged the buffering capacity at pH 2.4 to 120 min. Aluminum+magnesium hydroxides and calcium+magnesium carbonate combinations mainly exerted neutralizing activity, inducing an increase in the gastric emptying rate. In the duodenal ulcer simulation, the pH of the gastric contents was lower and the antacid effect was shorter than in the 'physiological' simulation.


Assuntos
Antiácidos/farmacologia , Simulação por Computador , Duodeno/fisiologia , Estômago/fisiologia , Alumínio/farmacologia , Alumínio/uso terapêutico , Antiácidos/uso terapêutico , Cálcio/farmacologia , Cálcio/uso terapêutico , Combinação de Medicamentos , Avaliação de Medicamentos , Refluxo Duodenogástrico/tratamento farmacológico , Técnicas In Vitro , Magnésio/farmacologia , Magnésio/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA